Director – Good Laboratory Practice Quality Assurance
Revolution Medicines
Director – Good Laboratory Practice Quality Assurance
Revolution Medicines
Clinical-stage oncology company developing RAS inhibitors
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
The Director, Good Laboratory Practice Quality Assurance (GLP QA) is responsible for ensuring Good Laboratory Practices (GLP) compliance at RevMed and external vendors contracted to perform regulated work on behalf of RevMed including all GLP vendors.
Responsibilities include research laboratory vendors that perform work to support regulated clinical studies.
Develops the annual vendor audit plan.
The Director GLP QA performs and/or manages vendor audits including:
Development of the audit plan, audit conduct, and reporting
Tracking and coordination of audit closure tasks including review of observation responses from vendor(s) in conjunction with operational subject matter experts (SMEs), as applicable.
Provision of vendor approval recommendations
Maintenance of vendor approval status in Veeva.
Development and/or review of Quality Agreements
Performs or participates in internal audits.
Provides QA review of CRO study protocols and reports for compliance utilizing a risk-based approach, as needed and serves as an advisor to the Nonclinical Development and Clinical Pharmacology (NDCP) to resolve compliance issues.
Monitors vendor QA units for compliance with applicable regulations including review of vendor study specific QA audit reports.
Advises Sponsor(s) on compliance requirements for test and control article used in GLP studies.
Liaises and/or consults with GLP vendor QA departments on study-related issues such as deviations, investigations, CAPAs and other compliance issues.
Provides annual GLP training or liaises with an external trainer to provide GLP training to RevMed functional team(s).
Attends functional area meetings (e.g., NDCP and Biomarker group) to discuss and review new or on-going issues, projects, and/or studies.
Works with QA management for resource planning, as needed.
Attends periodic clinical QA group meetings, as needed.
Provides periodic quality and compliance updates to QA management.
Develops/prepares standard operating procedure (SOPs) content to GLP audits, and reviews functional area and QA SOPs for GLP compliance.
Provides consultative QA guidance for computerized system vendors (and systems) supporting GLP studies.
Required Skills, Experience and Education:
Bachelor’s or Master’s Degree.
12+ years of experience in global Good Laboratory Practice (GLP) Quality Assurance (QA).
Extensive audit and inspection management experience.
Preferred Skills:
Registered Quality Assurance Professional – Good Laboratory Practice (RQAP-GLP).
Planning and scheduling expertise.
Experienced in effective prioritization of competing initiatives and tasks across multiple projects.
Ability to communicate effecttively with senior leadership, management and cross functional teams.
Ability to manage workstreams to maintain delivery timelines through disciplined planning, tracking and follow-up.
Ability to balance detail-oriented execution with strategic oversight.
Experienced with the proactive identification, assessment and mitigation of risks and with timely issue escalation, as applicable.
Regulatory expertise with at least the following regulations and guidance:
21CFR Part 58 Good Laboratory Practice.
21 CFR Part 11 Electronic Records; Electronic Signatures.
OECD #1 – 24 Standards and Advisory Documents on Good Laboratory Practices.
ICH E6 (R2 and R3) Good Clinical Practices.
Japanese Ministry of Health Labor and Welfare (MHLW) – Good Laboratory Practice.
Applicable US and EU guidance documents including bioanalytical, in vitro and in vivo genetic, Phototox, and hERG toxicology studies.
Experience with the following audit types
Testing facilities.
Bioanalytical and PK data analysis Labs.
hERG and Phototoxicity testing facilities.
Archives – biorepositories, paper and electronic data storage.
Computer Systems Validation.
Biomarker Labs (including Artificial Intelligence and Machine Learning).
Central Laboratories.
#LI-Hybrid #LI-JC1
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [email protected].
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to [email protected] so we can share these impersonations with our IT team for tracking and awareness.
Base Pay Salary Range 211000 - 264000 USD
Clinical-stage oncology company developing RAS inhibitors
Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.
Explore more opportunities at Revolution Medicines